ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
38.82
-0.49%
US Tech 100
19,011.20
0.78%
S&P 500
5,572.07
-0.76%
US Dollar vs CAD
1.4441
0.06%
Bitcoin
82,368.02
-0.58%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. BioCardia Inc (BCDA) Share Price

BioCardia Inc

BioCardia Inc (BCDA)

NASDAQ
2.57
0.03
(1.18%)
Closed March 11 3:00PM
Delayed by 15 minutes
2.57
0.00
( 0.00% )
Pre Market: 3:55AM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
2.57
Bid
2.23
Ask
2.98
Volume
-
0.00 Day's Range 0.00
1.625 52 Week Range 6.8655
Market Cap
11.782M
Previous Close
2.57
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
54,707
Shares Outstanding
4,584,285
Dividend Yield
-
PE Ratio
-1.02
Earnings Per Share (EPS)
-2.52
Revenue
477k
Net Profit
-11.57M

About BioCardia Inc

BioCardia Inc is a clinical stage regenerative medicine company. It is developing therapeutics for cardiovascular diseases with large unmet medical needs. The company is developing comprehensive biotherapeutic candidates for cardiac regenerative medicine namely CardiAMP and CardiALLO, with a focus o... BioCardia Inc is a clinical stage regenerative medicine company. It is developing therapeutics for cardiovascular diseases with large unmet medical needs. The company is developing comprehensive biotherapeutic candidates for cardiac regenerative medicine namely CardiAMP and CardiALLO, with a focus on heart failure resulting from a heart attack. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.biocardia.com
Headquarters
Wilmington, Delaware, USA
Founded
-
BioCardia Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker BCDA. The last closing price for BioCardia was US$2.57. Over the last year, BioCardia shares have traded in a share price range of US$ 1.625 to US$ 6.8655.

BioCardia currently has 4,584,285 shares outstanding. The market capitalization of BioCardia is US$11.78 million. BioCardia has a price to earnings ratio (PE ratio) of -1.02.

Ask ADVFN Intelligence (AI)

BCDA Latest News

More News

Form 8-K - Current report
Edgar (US Regulatory)
March 10 2025
BCDA (1.18%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
March 07 2025
BCDA (1.18%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
March 05 2025
BCDA (1.18%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
March 04 2025
BCDA (1.18%)

Form 8-K - Current report
Edgar (US Regulatory)
February 27 2025
BCDA (1.18%)

Form 8-K - Current report
Edgar (US Regulatory)
February 13 2025
BCDA (1.18%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.114.471544715452.462.722.4304922.5719358CS
40.156.198347107442.422.951.925529702.50439066CS
120.524.1545893722.072.951.625547072.35406316CS
26-0.12-4.460966542752.693.25841.625735822.56806622CS
52-4.105-61.49812734086.6756.86551.6253209533.90666093CS
156-28.33-91.682847896430.943.79851.62543160414.29715373CS
260-42.43-94.2888888889451291.62555611941.64478936CS

BCDA - Frequently Asked Questions (FAQ)

What is the current BioCardia share price?
The current share price of BioCardia is US$ 2.57
How many BioCardia shares are in issue?
BioCardia has 4,584,285 shares in issue
What is the market cap of BioCardia?
The market capitalisation of BioCardia is USD 11.78M
What is the 1 year trading range for BioCardia share price?
BioCardia has traded in the range of US$ 1.625 to US$ 6.8655 during the past year
What is the PE ratio of BioCardia?
The price to earnings ratio of BioCardia is -1.02
What is the cash to sales ratio of BioCardia?
The cash to sales ratio of BioCardia is 24.69
What is the reporting currency for BioCardia?
BioCardia reports financial results in USD
What is the latest annual turnover for BioCardia?
The latest annual turnover of BioCardia is USD 477k
What is the latest annual profit for BioCardia?
The latest annual profit of BioCardia is USD -11.57M
What is the registered address of BioCardia?
The registered address for BioCardia is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the BioCardia website address?
The website address for BioCardia is www.biocardia.com
Which industry sector does BioCardia operate in?
BioCardia operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AREBAmerican Rebel Holdings Inc
US$ 0.527
(73.41%)
7.32M
HCTIHealthcare Triangle Inc
US$ 0.4636
(42.65%)
8.28M
HFBLHome Federal Bancorp Inc of Louisiana
US$ 17.99
(42.38%)
1
CSPICSP Inc
US$ 22.00
(41.94%)
16
SSPEW Scripps Company
US$ 1.945
(36.01%)
831.35k
HEPAHepion Pharmaceuticals Inc
US$ 0.0497
(-40.83%)
5.54M
SYRSSyros Pharmaceuticals Inc
US$ 0.0969
(-28.75%)
1.17M
SERASera Prognostics Inc
US$ 3.01
(-28.67%)
4
ZYXIZynex Inc
US$ 5.08
(-27.43%)
2.82k
TNONTenon Medical Inc
US$ 1.14
(-24.50%)
258.65k
STISolidion Technology Inc
US$ 0.1406
(11.50%)
48.58M
HCTIHealthcare Triangle Inc
US$ 0.4636
(42.65%)
8.28M
AREBAmerican Rebel Holdings Inc
US$ 0.527
(73.41%)
7.32M
HEPAHepion Pharmaceuticals Inc
US$ 0.0497
(-40.83%)
5.54M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 8.45
(6.83%)
5.25M

BCDA Discussion

View Posts
Monksdream Monksdream 3 months ago
BCDA under $2
👍️0
Monksdream Monksdream 5 months ago
BCDA under $3
👍️0
al dean al dean 6 months ago
Yep-feeling trapped. BCDA down a bunch this Friday too, even with new drug approved. Friday seems, in general, to be a take down day as people are doing other things near weekend and MMs can work it down. Stock market is a weird world !
👍️0
Zorro Zorro 6 months ago
WBUY is always a trap. Staying away from anything Asian;)
👍️0
al dean al dean 6 months ago
You have good nose ! Sold all at $3.33 on guess sell limit--surprise. A couple days of shaking and it goes up some more is my guess. Stuck in WBUY at moment as tried to join party as party was breaking up--lol
👍️0
Zorro Zorro 6 months ago
Smelling news here.
👍️0
al dean al dean 6 months ago
Going right direction. WooHoo Turtle speed--but right direction now.
👍️0
al dean al dean 6 months ago
MMs finding some sellers for a while. Maybe I try for more shares.
👍️0
al dean al dean 6 months ago
Looks rather soft today as volume is down. So horde of seller is NOT happening is good. I think MMs get bored in 2 days and it creeps back up--my thoughts. I'm not selling unless a pop happens.
👍️0
Monksdream Monksdream 6 months ago
BCDA under $5
👍️0
NickDanger NickDanger 6 months ago
I think the 7.2mil may come from adding what the warrant holders can do? I don't know. But yes, I think they are going about enlarging the share structure intelligently. We'll see on the 3rd I guess. Weeee!
👍️0
al dean al dean 6 months ago
I made mistake of thinking new shares amounted to 7.2 million. New share amount is 4.8 M As shares priced at $3, this will not dip too far. Some are already added.so not expecting disaster like some stock adding shares.
👍️0
NickDanger NickDanger 6 months ago
Looks like their new share offering will be around $3 per share - https://www.globenewswire.com/news-release/2024/08/30/2938478/0/en/BioCardia-Announces-Pricing-of-Upsized-7-2-Million-Public-Offering-Priced-At-The-Market-Under-Nasdaq-Rules.html
👍️0
NickDanger NickDanger 6 months ago
Another 2.4 million issued under the same terms - https://ih.advfn.com/stock-market/NASDAQ/biocardia-BCDA/stock-news/94464814/form-s-1mef-registration-adding-securities-to-pr Hope this puppy can still keep treading water. Tomorrow's Friday, depending on who's buying this they may not want to hold over the weekend.
👍️0
NickDanger NickDanger 6 months ago
Well, those new shares being issued at half price are going to make it dip. Lot more to do with it than people's fear about it. But I've seen a lot of these Otc's, Pinky's and microcap Biopharma's issue a crapload of new shares right after news and a huge pop and then the share price collapses and people are stuck for months. Sometimes they never recover. The fact that BCDA absorbed them and moved into the 4's at end of day is pretty significant imo. The interest in buying it up in the low 3's means significant money likes the future outlook. Weeeeeeee! Microcap Biopharma!
👍️0
it_happens it_happens 6 months ago
I think that maybe people read both releases by now. Climbing up nicely. This never should have dipped so low. Some traders got a good deal today.
👍️ 1
NickDanger NickDanger 6 months ago
Interesting, thx. It looks like it might have legs...
👍️0
PirateLeviathan8 PirateLeviathan8 6 months ago
At the moment, the trend is more towards $4 than $2
And such orders can be found Level 2 almost everywhere, but mostly these are so-called iceberg orders, where you only see a few thousand but there are hundreds of thousands behind them.
But in this day and age of electronic algorithms, this type of trading is relatively pointless and is no longer done.
Today's trading systems replenish certain positions again and again, buy and sell according to corresponding specifications and forward these promptly to the stock exchanges. This is why you can hardly find any relevant orders in the order books these days.
👍️0
it_happens it_happens 6 months ago
I have an L2. Volume is brisk right now. No walls set up on the ASK. 1700 shares is the highest. Most are 100 shares which most likely means the MMs aren't showing all of the shares they are selling at that PPS.
👍️0
NickDanger NickDanger 6 months ago
Do you have Level 2 on this? Curious what the ask prices are for the top 3-4 market makers. Also wondering if someone is holding out for a giant buy order in the $2something range.
👍️0
NickDanger NickDanger 6 months ago
On doing some more research around the inter-webs; Morningstar has given them a 5 star ranking and other ranking sites make it a moderate buy. So, apparently they're not full of crap. If it hangs around $3 for the close I'll be hopeful for it's future. ("it's called an investment", lolzzz thx.)
👍️0
it_happens it_happens 6 months ago
Also, it's not like the offering was needed to keep the lights on. The money gained from the offering will most likely go toward increased production of the approved product. It's called an investment. The company should realize good profits from the investment.
👍️ 1
PirateLeviathan8 PirateLeviathan8 6 months ago
I have traded so many shares in the last few weeks and months that have issued new shares or announced new shares and closed in these huge volumes within the day.

You can see from the trading that the share wants to rise and will rise in line with the positive approval and the expected increase in profits and income.

It is simply our basic evil with these short addresses that are now headlessly beating up on every share that is even slightly up, regardless of whether there is good or bad news.

But this headless beating on shares very often brings the next 100-200% plus in trading the next day, because they then close the open positions as quickly as possible at all costs and then try the game all over again later out of sheer anger.
It is therefore no wonder why so many of them go bust. Well, it's not their money, but only that of their investors in these funds.
👍️0
NickDanger NickDanger 6 months ago
On a more general low float runner note; people always complain about "dilution" in penny stocks. But the reality is, if it's not a complete scam company who are just selling their shares into the pump, they have to issue more shares for there to be an increase in share price with the increase in attention and volume. These things don't really move up much or best case run way up with only a 1.5 million float. If I had got in and was down 30-50% I would just hang around and wait. I'm going to keep an eye on it anyway. An analyst, H.C. Wainright, whoever the hell that is, has put a price target of $25 per share on this thing. So, who knows. cheers!
👍️0
PirateLeviathan8 PirateLeviathan8 6 months ago
With a current volume of 26.6 million, they won't wait a few days to see what happens and then issue new shares days later.
With today's volume, these announced new shares are already included three times or more in the volume and they can therefore be completed in one day and then celebrate the approval accordingly in the price the following days and generate a high increase.
There are only shorts at work here who think they can beat down the price with all their might and completely ignore the approval and the very good news that comes with it.
They have to cover their open positions very quickly otherwise the shot could backfire badly.
👍️0
NickDanger NickDanger 6 months ago
The total shares outstanding are 1.58 million, the float is 1.5 million. https://finviz.com/quote.ashx?t=BCDA&p=d Those issued shares and 2 types of warrants effectively triple the float. The shares can be bought at $2.47, the pre-funded warrants can be exercised immediately at .001. They can issue them at any time and in any amounts they want; so maybe parcel them out over the coming days, but I don't see how it cannot effect the share price in the near term. Just my non-professional, non-expert opinion. If their suite of catheter tools is something really new and different this will probably make everyone money. It's just going to be a buy and hold instead of a flip. I was going to get in this but saw that S-1 and changed my mind. I don't like to buy and hold. But, no one can predict the future. We'll see in the next couple of days. glta
👍️0
it_happens it_happens 6 months ago
Glad you see it the way I do. That 2m shares in a drop in the bucket.
👍️ 1
PirateLeviathan8 PirateLeviathan8 6 months ago
With a trading volume of 22 million, what are 2.6 million new shares, they have long since been traded and the share price even rose further in the pre-market after this announcement.

A few shorts are only trading on this news with the new shares and are completely ignoring the top news.
I am sure that the share will turn around well today.
👍️0
it_happens it_happens 6 months ago
I don't see why the offering of 2,439,024 would tank the PPS the way it did. The offering shouldn't negate the news in the other PR. Maybe it will bounce back today.
👍️0
Invest-in-America Invest-in-America 6 months ago
BCDA: And indeed it DID, Dude; wherefore, a classic TOILET FLUSH on the Public --- as this Firm ramps-up to DUMP yet more shares onto the Wall Street 'playing field'.
👍️0
NickDanger NickDanger 6 months ago
If you're looking at the same screen I am there's a column of "Latest News" just to the right of the message board. The second press release down is a form S-1A released at 6:02am. I believe it has a strong bearing on which direction the price will take.
👍️0
PirateLeviathan8 PirateLeviathan8 6 months ago
The News is top, it will bounce back around 5 bucks +
👍️0
it_happens it_happens 6 months ago
Wonder if it will bounce back over $4. It dropped fast at the bell.
👍️0
Zorro Zorro 6 months ago
Nice subs! Let's make some money.
👍️0
subslover subslover 6 months ago
NEWS_ BioCardia receives FDA clearance for new product
https://www.investing.com/news/company-news/biocardia-receives-fda-clearance-for-new-product-93CH-3592035
👍️0
Helter Skelter Helter Skelter 6 months ago
$BCDA +110% @ 4.62 in premarket on volume...
👍️0
Zorro Zorro 6 months ago
That's what I was thinking as well. Huge market for the drugs approved for sale.
👍️0
NickDanger NickDanger 6 months ago
BCDA 8k - If they issue a press release for this tomorrow morning should get real volume and keep moving up. https://ih.advfn.com/stock-market/NASDAQ/biocardia-BCDA/stock-news/94456844/form-8-k-current-report
👍️0
NickDanger NickDanger 6 months ago
They also submitted this for approval in July - https://www.biospace.com/biocardia-submits-for-fda-approval-of-morph-dna-steerable-introducer-product-family maybe it got approved?
Edit - here it is, looks like it's approved - https://ih.advfn.com/stock-market/NASDAQ/biocardia-BCDA/stock-news/94456844/form-8-k-current-report
👍️0
Invest-in-America Invest-in-America 6 months ago
BCDA; Did what?????? (NOTHING)
👍️0
Monksdream Monksdream 6 months ago
Whoops, I did it, again
👍️0
Monksdream Monksdream 6 months ago
BCDA new 52 low
👍️0
Monksdream Monksdream 7 months ago
BCDA new 52=week low
👍️0
Awl416 Awl416 7 months ago
FDA Approves CardiAMP® Heart Failure II Protocol Amendment to Use Proprietary Cell Population Analysis Screening to Define Treatment
👍️0
Monksdream Monksdream 7 months ago
BCDA under $3
👍️0
Monksdream Monksdream 8 months ago
BCDA under $3
👍️0
JB40 JB40 8 months ago
Understand and agree. They get little to no traction on the market. Although, most important imo is they do get traction with the largest health insurer in the country putting millions into BCDA's trials. Bizarre to me that few are paying attention to such a large indication as I'm sure you are aware with them being in such a late stage of their trials. Small burn and only need a small amount of capital to get to the Phase 3 readout. They already have 90% of the Phase 3 BCDA01 data, so I guess we will see what happens with the final data set.
👍️0
murocman murocman 8 months ago
Yes. Have a personal interest as I have heart disease.

Have traded it sporadically.

Disappointed that don’t ever seem to get much traction with this therapy even with good data.

Murocman
👍️0
JB40 JB40 8 months ago
Been tracking this company for years. Anyone else?
👍️0
Monksdream Monksdream 9 months ago
BCDA new 52 week low
👍️0

Your Recent History

NASDAQ
BCDA
BioCardia
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads